Mira Goldberg - McMaster Experts

Affiliations

Faculty of Health Sciences, McMaster University
Full-Time Member, Escarpment Cancer Research Institute (ECRI), Faculty of Health Sciences
Assistant Professor, Oncology, Faculty of Health Sciences

Scholarly Activity in McMaster Experts

Co-author Network

Scholarly Activity
Research
Contact
View All

selected scholarly activity

conferences
- STEREOTACTIC BODY RADIATION THERAPY (SBRT) AND HYPO-FRACTIONATED RADIATION THERAPY (HFRT) OUTCOMES FOR LOW AND INTERMEDIATE-RISK PROSTATE CANCER (PRCA): EXPERIENCE AT TWO ONTARIO CENTRES. Radiotherapy and Oncology. S53-S53. 2023
- Radical Chest Wall Resection and Hyperfractionated Accelerated Radiotherapy (Hart)for Radiation-Associated Angiosarcoma of the Breast: 15 Years of Safe and Effective Treatment. Annals of Surgical Oncology. S242-S242. 2023
- PROSTATE SBRT BOOST RADIOTHERAPY (PBS TRIAL): A RANDOMIZED PHASE II TRIAL OF SBRT VERSUS CONVENTIONALLY-FRACTIONATED RADIOTHERAPY BOOST FOLLOWING PELVIC RADIOTHERAPY IN HIGH-RISK PROSTATE CANCER. Radiotherapy and Oncology. S64-S64. 2021
- A RANDOMIZED PHASE II TRIAL OF PROSTATE BOOST IRRADIATION WITH STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN HIGH-RISK PROSTATE CANCER. THE PBS TRIAL. Radiotherapy and Oncology. S87-S88. 2020
- Abstract P2-18-01: Single modality adjuvant therapy with radiation (RT) alone or endocrine therapy (ET) alone in women ≥65 years with early stage, hormone receptor positive breast cancer treated with breast-conserving surgery: A population-based analysis. Cancer Research. 2020
- Abstract P5-12-06: Non-adherence to endocrine therapy is associated with a significant increased risk of local recurrence in women ≥65 years with stage T1N0 breast cancer treated with adjuvant endocrine therapy alone after breast-conserving surgery. Cancer Research. 2020
- Abstract P6-16-01: Refined local recurrence risk estimates based on a multigene expression assay combined with clinicopathological features significantly impacts radiotherapy recommendation in patients with low/intermediate risk DCIS treated with breast-conserving surgery. Cancer Research. 2020
- Long-Term Outcomes of Microinvasive Breast Cancer in the Canadian Hypofractionation Trial. International Journal of Radiation Oncology Biology Physics. S56-S57. 2017
- Photodynamic Therapy (PDT) With Porfimer Sodium Sensitizer Using HDR Planning Principles: A Single-Institution Experience of an Alternative Cancer Treatment. International Journal of Radiation Oncology Biology Physics. E476-E477. 2015
- A case series of Lynch syndrome-associated breast cancer.. Journal of Clinical Oncology. 432-432. 2014
- A Preliminary Series of the Use of Stereotactic Radiosurgery (SBRT) in High-Risk Head-and-Neck Cancer. International Journal of Radiation Oncology Biology Physics. S429-S430. 2013
- Long-Term Follow-Up of Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.. Blood. 3032-3032. 2006
journal articles
- Patterns of failure with 18F-DCFPyL PSMA-PET/CT in the post-prostatectomy setting: A regional cohort analysis.. Journal of the Canadian Urological Association. 19. 2024
- Stereotactic Body Radiotherapy (SBRT) vs. Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for Unfavorable Intermediate and High-Risk Prostate Cancer; Early Results of PBS: A Phase II Randomized Trial (NCT03380806). International Journal of Radiation Oncology Biology Physics. 120:s126-s127. 2024
- 23 Stereotactic Body Versus Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for High-Risk Prostate Cancer (HR-PC); Early Results of PBS: A Phase II Randomized Trial (NCT03380806). Radiotherapy and Oncology. 198:s13-s14. 2024
- Disease control outcomes of stereotactic body radiation therapy or moderate hypo‐fractionation for prostate cancer: Real‐world experience at two Canadian centers. Prostate. 84:193-202. 2024
- 114 Stereotactic Body Radiation Therapy (SBRT) and Hypo-Fractionated Radiation Therapy (HFRT) Outcomes for Low and Intermediate-Risk Prostate Cancer (PRCA): Experience at Two Ontario Centres. Radiotherapy and Oncology. 186:S53-S53. 2023
- Long-term outcomes and effects of hypofractionated radiotherapy in microinvasive breast cancer: Analysis from a randomized trial. Breast. 68:189-193. 2023
- In Response to Morgan et al. and Li et al.. International Journal of Radiation Oncology Biology Physics. 115:1012-1013. 2023
- Biochemical disease control outcomes of stereotactic body radiation therapy (SBRT) or moderate hypo-fractionation (HFRT) for low- and intermediate-risk prostate cancer (PrCa): Retrospective analysis of 12 years of experience at two Canadian cancer centers.. Journal of Clinical Oncology. 41:363-363. 2023
- Patterns of failure after radiotherapy (RT) in patients with prostate cancer re-staged with ¹⁸F-DCFPyL PSMA-PET: A regional cohort analysis.. Journal of Clinical Oncology. 41:45-45. 2023
- Patterns of failure with ¹⁸F-DCFPyL PSMA PET/CT in the post-prostatectomy setting: A regional cohort analysis.. Journal of Clinical Oncology. 41:309-309. 2023
- A Meta-Analysis of Trials of Partial Breast Irradiation. International Journal of Radiation Oncology Biology Physics. 115:60-72. 2023
- Salvage radiotherapy following HiFU: An institutional series and literature review. Journal of Medical Imaging and Radiation Oncology. 66:847-852. 2022
- 151: Prostate SBRT Boost Radiotherapy (PBS Trial): A Randomized Phase II Trial of SBRT Versus Conventionally-Fractionated Radiotherapy Boost Following Pelvic Radiotherapy in High-Risk Prostate Cancer. Radiotherapy and Oncology. 163:S64-S64. 2021
- DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS. Breast Cancer Research and Treatment. 188:133-139. 2021
- Accelerated Partial Breast Irradiation (APBI): Where Are We Now?. Current Breast Cancer Reports. 12:275-284. 2020
- 206: A Randomized Phase Ii Trial of Prostate Boost Irradiation with Stereotactic Body Radiotherapy (SBRT) in High-Risk Prostate Cancer. The Pbs Trial. Radiotherapy and Oncology. 150:S87-S88. 2020
- A Randomized Phase II Trial of Prostate Boost Irradiation With Stereotactic Body Radiotherapy (SBRT) or Conventional Fractionation (CF) External Beam Radiotherapy (EBRT) in Locally Advanced Prostate Cancer: The PBS Trial (NCT03380806). Clinical Genitourinary Cancer. 18:e410-e415. 2020
- Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast Cancer. International Journal of Radiation Oncology Biology Physics. 107:943-948. 2020
- Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery. Breast Cancer Research and Treatment. 178:169-176. 2019
- Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis. Breast Cancer Research and Treatment. 176:657-667. 2019
- Systemic Effects of Radiotherapy in Ductal Carcinoma In Situ. JAMA network open. 1:e181102-e181102. 2018
- Association between the Lynch syndrome gene MSH2 and breast cancer susceptibility in a Canadian familial cancer registry. Journal of Medical Genetics. 54:742-746. 2017
- A prospective analysis of high-dose-rate endobronchial brachytherapy in the palliation of obstructive symptoms in lung cancer patients: A single-institution experience. Brachytherapy. 14:655-661. 2015
- A Prospective Study of the Utility of Magnetic Resonance Imaging in Determining Candidacy for Partial Breast Irradiation. International Journal of Radiation Oncology Biology Physics. 85:615-622. 2013
- Radiation recall dermatitis induced by a second course of radiation therapy in the absence of clinically significant field overlap. Oncology in Clinical Practice.